{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2024,2,10]],"date-time":"2024-02-10T00:34:30Z","timestamp":1707525270773},"reference-count":17,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2023,9,11]]},"DOI":"10.7759\/cureus.45004","type":"journal-article","created":{"date-parts":[[2023,9,11]],"date-time":"2023-09-11T07:15:32Z","timestamp":1694416532000},"source":"Crossref","is-referenced-by-count":0,"title":["Solvent-Induced Raynaud\u2019s Phenomenon"],"prefix":"10.7759","author":[{"given":"Helena","family":"Rodrigues","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Catarina","family":"Reigota","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Carolina","family":"Teles","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"S\u00f3nia","family":"Moreira","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"L\u00e8lita","family":"Santos","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(00)05118-7","article-title":"Raynaud\u2019s phenomenon","volume":"357","author":"Block JA","year":"2001","unstructured":"Block JA, Sequeira W. Raynaud\u2019s phenomenon. Lancet. 2001, 357:2042-8. 10.1016\/S0140-6736(00)05118-7","journal-title":"Lancet"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.1024\/0301-1526\/a000661","article-title":"ESVM guidelines - the diagnosis and management of Raynaud's phenomenon","volume":"46","author":"Belch J","year":"2017","unstructured":"Belch J, Carlizza A, Carpentier PH, et al.. ESVM guidelines - the diagnosis and management of Raynaud's phenomenon. Vasa. 2017, 46:413-23. 10.1024\/0301-1526\/a000661","journal-title":"Vasa"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaut.2014.01.020","article-title":"International consensus criteria for the diagnosis of Raynaud's phenomenon","volume":"48-49","author":"Maverakis E","year":"2014","unstructured":"Maverakis E, Patel F, Kronenberg DG, et al.. International consensus criteria for the diagnosis of Raynaud's phenomenon. J Autoimmun. 2014, 48-49:60-5. 10.1016\/j.jaut.2014.01.020","journal-title":"J Autoimmun"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.1177\/1358863X20983455","article-title":"Raynaud's phenomenon and related vasospastic disorders","volume":"26","author":"Choi E","year":"2021","unstructured":"Choi E, Henkin S. Raynaud's phenomenon and related vasospastic disorders. Vasc Med. 2021, 26:56-70. 10.1177\/1358863X20983455","journal-title":"Vasc Med"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.1093\/rheumatology\/keh552","article-title":"Pathogenesis of Raynaud's phenomenon","volume":"44","author":"Herrick AL","year":"2005","unstructured":"Herrick AL. Pathogenesis of Raynaud's phenomenon. Rheumatology (Oxford). 2005, 44:587-96. 10.1093\/rheumatology\/keh552","journal-title":"Rheumatology (Oxford)"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.1152\/ajpheart.00306.2007","article-title":"Estrogen increases smooth muscle expression of alpha2C-adrenoceptors and cold-induced constriction of cutaneous arteries","volume":"293","author":"Eid AH","year":"2007","unstructured":"Eid AH, Maiti K, Mitra S, et al.. Estrogen increases smooth muscle expression of alpha2C-adrenoceptors and cold-induced constriction of cutaneous arteries. Am J Physiol Heart Circ Physiol. 2007, 293:H1955-61. 10.1152\/ajpheart.00306.2007","journal-title":"Am J Physiol Heart Circ Physiol"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.3389\/fphar.2016.00438","article-title":"Raynaud\u2019s phenomenon: a brief review of the underlying mechanisms","volume":"7","author":"Fardoun MM","year":"2016","unstructured":"Fardoun MM, Nassif J, Issa K, Baydoun E, Eid AH. Raynaud\u2019s phenomenon: a brief review of the underlying mechanisms. Front Pharmacol. 2016, 7:438. 10.3389\/fphar.2016.00438","journal-title":"Front Pharmacol"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.1136\/bmjopen-2014-006389","article-title":"Prevalence, risk factors and associations of primary Raynaud's phenomenon: systematic review and meta-analysis of observational studies","volume":"5","author":"Garner R","year":"2015","unstructured":"Garner R, Kumari R, Lanyon P, Doherty M, Zhang W. Prevalence, risk factors and associations of primary Raynaud's phenomenon: systematic review and meta-analysis of observational studies. BMJ Open. 2015, 5:e006389. 10.1136\/bmjopen-2014-006389","journal-title":"BMJ Open"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.1016\/S0889-857X(21)01041-3","article-title":"Microvasculature in systemic sclerosis","volume":"16","author":"Carpentier PH","year":"1990","unstructured":"Carpentier PH, Maricq HR. Microvasculature in systemic sclerosis. Rheum Dis Clin North Am. 1990, 16:75-91. 10.1016\/S0889-857X(21)01041-3","journal-title":"Rheum Dis Clin North Am"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0051506","article-title":"Organic solvents as risk factor for autoimmune diseases: a systematic review and meta-analysis","volume":"7","author":"Barrag\u00e1n-Mart\u00ednez C","year":"2012","unstructured":"Barrag\u00e1n-Mart\u00ednez C, Speck-Hern\u00e1ndez CA, Montoya-Ortiz G, Mantilla RD, Anaya JM, Rojas-Villarraga A. Organic solvents as risk factor for autoimmune diseases: a systematic review and meta-analysis. PLoS One. 2012, 7:e51506. 10.1371\/journal.pone.0051506","journal-title":"PLoS One"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.1093\/alcalc\/agq028","article-title":"Vascular actions of nitric oxide as affected by exposure to alcohol","volume":"45","author":"Toda N","year":"2010","unstructured":"Toda N, Ayajiki K. Vascular actions of nitric oxide as affected by exposure to alcohol. Alcohol Alcohol. 2010, 45:347-55. 10.1093\/alcalc\/agq028","journal-title":"Alcohol Alcohol"},{"key":"ref12","article-title":"Relationship between occupational risk factors and severity markers of systemic sclerosis","volume":"32","author":"Magnant J","year":"2005","unstructured":"Magnant J, de Monte M, Guilmot JL, et al.. Relationship between occupational risk factors and severity markers of systemic sclerosis. J Rheumatol. 2005, 32:1713-8.","journal-title":"J Rheumatol"},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.3899\/jrheum.101129","article-title":"Raynaud's phenomenon in medical laboratory workers who work with solvents","volume":"38","author":"Purdie GL","year":"2011","unstructured":"Purdie GL, Purdie DJ, Harrison AA. Raynaud's phenomenon in medical laboratory workers who work with solvents. J Rheumatol. 2011, 38:1940-6. 10.3899\/jrheum.101129","journal-title":"J Rheumatol"},{"key":"ref14","doi-asserted-by":"publisher","DOI":"10.1093\/aje\/kwf223","article-title":"Scleroderma and solvent exposure among women","volume":"157","author":"Garabrant DH","year":"2003","unstructured":"Garabrant DH, Lacey JV Jr, Laing TJ, Gillespie BW, Mayes MD, Cooper BC, Schottenfeld D. Scleroderma and solvent exposure among women. Am J Epidemiol. 2003, 157:493-500. 10.1093\/aje\/kwf223","journal-title":"Am J Epidemiol"},{"key":"ref15","doi-asserted-by":"publisher","DOI":"10.1136\/oem.59.8.545","article-title":"Systemic sclerosis and occupational risk factors: a case-control study","volume":"59","author":"Diot E","year":"2002","unstructured":"Diot E, Lesire V, Guilmot JL, et al.. Systemic sclerosis and occupational risk factors: a case-control study. Occup Environ Med. 2002, 59:545-9. 10.1136\/oem.59.8.545","journal-title":"Occup Environ Med"},{"key":"ref16","doi-asserted-by":"publisher","DOI":"10.1038\/nrrheum.2014.195","article-title":"A vascular mechanistic approach to understanding Raynaud phenomenon","volume":"11","author":"Flavahan NA","year":"2015","unstructured":"Flavahan NA. A vascular mechanistic approach to understanding Raynaud phenomenon. Nat Rev Rheumatol. 2015, 11:146-58. 10.1038\/nrrheum.2014.195","journal-title":"Nat Rev Rheumatol"},{"key":"ref17","doi-asserted-by":"publisher","DOI":"10.1136\/annrheumdis-2016-209909","article-title":"Update of EULAR recommendations for the treatment of systemic sclerosis","volume":"76","author":"Kowal-Bielecka O","year":"2017","unstructured":"Kowal-Bielecka O, Fransen J, Avouac J, et al.. Update of EULAR recommendations for the treatment of systemic sclerosis. Ann Rheum Dis. 2017, 76:1327-39. 10.1136\/annrheumdis-2016-209909","journal-title":"Ann Rheum Dis"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/182913-solvent-induced-raynauds-phenomenon","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,2,9]],"date-time":"2024-02-09T20:04:48Z","timestamp":1707509088000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/182913-solvent-induced-raynauds-phenomenon"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,9,11]]},"references-count":17,"URL":"https:\/\/doi.org\/10.7759\/cureus.45004","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2023,9,11]]}}}